HSIUHUI CHIEN: Open Payments
NPI 1902146780 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,366 in 74 payments from 19 companies in 2025. Trend: 2023 $1,056 · 2024 $1,090 · 2025 $1,366
Food & beverage: $1,366
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $206 |
| Lilly USA, LLC | 10 | $163 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $152 |
| AstraZeneca Pharmaceuticals LP | 8 | $142 |
| Corcept Therapeutics | 3 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80 |
| Astellas Pharma US Inc | 4 | $70 |
| PFIZER INC. | 3 | $66 |
| Xeris Pharmaceuticals, Inc. | 3 | $58 |
| ABBVIE INC. | 3 | $55 |
Products named: Kerendia, MOUNJARO, AIRSUPRA, JARDIANCE, Korlym, Wegovy, Ozempic, Veozah.
Industry payments across TX — which companies pay providers there.
